Literature DB >> 22531627

Application of fusion protein 4D5 scFv-dibarnase:barstar-gold complex for studying P185HER2 receptor distribution in human cancer cells.

Julia L Ivanova1, Evelina F Edelweiss, Olga G Leonova, Taras G Balandin, Vladimir I Popenko, Sergey M Deyev.   

Abstract

Overexpression of the P185(HER2) protein determines the malignancy and unfavorable prognosis of ovarian and breast tumors. In this work, the distribution of P185(HER2) in human cancer cells was studied by electron microscopy, using a novel approach. It is based on the interaction between barnase (a ribonuclease from Bacillus amyloliquefaciens) and its specific inhibitor barstar. The monoclonal antibody 4D5 scFv to extracellular P185(HER2) domain fused with two molecules of barnase was used as a recognizing agent, and the conjugate of colloidal gold with barstar, as an electron dense label for electron microscopic visualization. For labeling, we used supramolecular complexes 4D5 scFv-dibarnase:barstar-Au. The distribution of P185(HER2) in human ovarian carcinoma cells SKOV-3 and breast carcinoma cells BT-474 was studied at 4 °C and 37 °C. It was shown that at 4 °C the protein P185(HER2) occurs exclusively on the cell surface, mainly on protrusions or close to their bases. At 37 °C, the internalization of P185(HER2) caused by its interaction with 4D5 scFv-dibarnase was observed. Inside the cells, P185(HER2) was located in the coated pits and vesicles, endosomes and multivesicular bodies. The data obtained indicate that the supramolecular 4D5 scFv-dibarnase:barstar-gold complex can be used as a new immunodetection system for exploring the P185(HER2) distribution.
Copyright © 2012 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22531627     DOI: 10.1016/j.biochi.2012.04.011

Source DB:  PubMed          Journal:  Biochimie        ISSN: 0300-9084            Impact factor:   4.079


  6 in total

1.  PMCA2 regulates HER2 protein kinase localization and signaling and promotes HER2-mediated breast cancer.

Authors:  Jaekwang Jeong; Joshua N VanHouten; Pamela Dann; Wonnam Kim; Catherine Sullivan; Herbert Yu; Lance Liotta; Virginia Espina; David F Stern; Peter A Friedman; John J Wysolmerski
Journal:  Proc Natl Acad Sci U S A       Date:  2016-01-04       Impact factor: 11.205

2.  Inhibition of ezrin causes PKCα-mediated internalization of erbb2/HER2 tyrosine kinase in breast cancer cells.

Authors:  Jaekwang Jeong; Jungmin Choi; Wonnam Kim; Pamela Dann; Farzin Takyar; Julia V Gefter; Peter A Friedman; John J Wysolmerski
Journal:  J Biol Chem       Date:  2018-11-21       Impact factor: 5.157

3.  The scaffolding protein NHERF1 regulates the stability and activity of the tyrosine kinase HER2.

Authors:  Jaekwang Jeong; Joshua N VanHouten; Wonnam Kim; Pamela Dann; Catherine Sullivan; Jungmin Choi; W Bruce Sneddon; Peter A Friedman; John J Wysolmerski
Journal:  J Biol Chem       Date:  2017-02-24       Impact factor: 5.157

4.  A novel bifunctional hybrid with marine bacterium alkaline phosphatase and Far Eastern holothurian mannan-binding lectin activities.

Authors:  Larissa Balabanova; Vasily Golotin; Svetlana Kovalchuk; Alexander Bulgakov; Galina Likhatskaya; Oksana Son; Valery Rasskazov
Journal:  PLoS One       Date:  2014-11-14       Impact factor: 3.240

5.  Internalization and Recycling of the HER2 Receptor on Human Breast Adenocarcinoma Cells Treated with Targeted Phototoxic Protein DARPinminiSOG.

Authors:  O N Shilova; G M Proshkina; E N Lebedenko; S M Deyev
Journal:  Acta Naturae       Date:  2015 Jul-Sep       Impact factor: 1.845

6.  A Mansonone Derivative Coupled with Monoclonal Antibody 4D5-Modified Chitosan Inhibit AKR1C3 to Treat Castration-Resistant Prostate Cancer.

Authors:  Meng Zhou; Xiaoyu Wang; Jie Xia; Yating Cheng; Lichun Xiao; Yu Bei; Jianzhong Tang; Yadong Huang; Qi Xiang; Shiliang Huang
Journal:  Int J Nanomedicine       Date:  2020-05-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.